Information Provided By:
Fly News Breaks for February 5, 2016
ALXN
Feb 5, 2016 | 06:02 EDT
Leerink analyst Geoffrey Porges resumed coverage of Alexion Pharmaceuticals with an Outperform rating and $217 price target.
News For ALXN From the Last 2 Days
There are no results for your query ALXN